131 related articles for article (PubMed ID: 7540730)
1. [Hepatitis-C virus antibody conversion in 3 hemodialysis patients in various dialysis departments].
Schneeberger PM; Hoogenboom-Verdegaal A; van Es A; Schreuder H
Ned Tijdschr Geneeskd; 1995 Jun; 139(23):1187-90. PubMed ID: 7540730
[TBL] [Abstract][Full Text] [Related]
2. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays.
Chan TM; Lok AS; Cheng IK; Chan RT
Hepatology; 1993 Jan; 17(1):5-8. PubMed ID: 7678575
[TBL] [Abstract][Full Text] [Related]
4. [Epidemiology of hepatitis C virus infection in hemodialysis. A study of the Gargano area].
Aucella F; Martini E; Centra M; Di Tullio M; Di Giorgio G; Stallone C
Recenti Prog Med; 1995 Sep; 86(9):332-5. PubMed ID: 7569292
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence of hepatitis C virus antibodies in a hemodialysis unit].
Rodríguez MI; Estay R; Soto JR; Wolff C; Plubins L; Child R; Armas R
Rev Med Chil; 1993 Feb; 121(2):152-5. PubMed ID: 7508140
[TBL] [Abstract][Full Text] [Related]
6. Late seroconversion of C virus markers in hemodialysis patients.
Oliva JA; Maymo RM; Carrio J; Delgado O; Mallafre JM
Kidney Int Suppl; 1993 Jun; 41():S153-6. PubMed ID: 7686592
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of chronic hepatitis C virus infection in patients on maintenance haemodialysis.
Ozyilkan E; Akpolat T; Arik N; Köseoglu HT; Telatar H
Nephrol Dial Transplant; 1994; 9(11):1697-8. PubMed ID: 7532840
[No Abstract] [Full Text] [Related]
8. Anti-hepatitis C virus antibodies and hepatitis C virus viraemia in haemodialysis patients.
Picciotto A; Varagona G; Gurreri G; Fiorini F; Sofia A; Coviello DA; Bonanni P; Icardi GC; Valle F; Celle G
Nephrol Dial Transplant; 1993; 8(10):1115-7. PubMed ID: 8272226
[TBL] [Abstract][Full Text] [Related]
9. [Serological results for hepatitis C in hemodialysis patients].
Jordán M; Vila B; Carsi F; Martínez F; Font I
Enferm Infecc Microbiol Clin; 1992; 10(6):382. PubMed ID: 1327172
[No Abstract] [Full Text] [Related]
10. Hepatitis C virus and hemodialysis.
Mehta K; Hakim A
J Assoc Physicians India; 1999 Dec; 47(12):1137-8. PubMed ID: 11225210
[No Abstract] [Full Text] [Related]
11. Antibodies to hepatitis C virus by second generation test in hemodialyzed patients.
Chauveau P; Courouce AM; Lemarec N; Naret C; Poignet JL; Girault A; Ramdame M; Delons S
Kidney Int Suppl; 1993 Jun; 41():S149-52. PubMed ID: 7686591
[TBL] [Abstract][Full Text] [Related]
12. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients.
Lok AS; Chien D; Choo QL; Chan TM; Chiu EK; Cheng IK; Houghton M; Kuo G
Hepatology; 1993 Sep; 18(3):497-502. PubMed ID: 7689528
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission; persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunoblotting pattern.
Manzini P; Saracco G; Cerchier A; Riva C; Musso A; Ricotti E; Palomba E; Scolfaro C; Verme G; Bonino F
Hepatology; 1995 Feb; 21(2):328-32. PubMed ID: 7843701
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus and intravenous anti-D immunoglobulin.
Commun Dis Rep CDR Wkly; 1995 Jun; 5(24):111, 114. PubMed ID: 7542122
[No Abstract] [Full Text] [Related]
16. Identification of hepatitis C virus seroconversion resulting from nosocomial transmission on a haemodialysis unit: implications for infection control and laboratory screening.
Irish DN; Blake C; Christophers J; Craske JE; Burnapp L; Abbs IC; MacMahon EM; Muir P; Banatvala JE; Simmonds P
J Med Virol; 1999 Oct; 59(2):135-40. PubMed ID: 10459146
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C antibody in renal transplant patients.
Klauser R; Franz M; Traindl O; Pidlich J; Hay U; Watschinger B; Pohanka E; Kovarik J
Transplant Proc; 1992 Feb; 24(1):286-8. PubMed ID: 1371619
[No Abstract] [Full Text] [Related]
18. The impact of polymerase chain reaction assays for the detection of hepatitis C virus infection in a hemodialysis unit.
Hussein MM; Mooij JM; Hegazy MS; Bamaga MS
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):107-13. PubMed ID: 17237902
[TBL] [Abstract][Full Text] [Related]
19. De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay.
Fabrizi F; de Vecchi AF; Como G; Lunghi G; Martin P
Aliment Pharmacol Ther; 2005 Apr; 21(7):861-9. PubMed ID: 15801921
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
